Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RayzeBio
Biotech
BMS more likely to bet on bolt-ons after recent buying spree
Bristol Myers Squibb is focused on integrating its new acquisitions, but CEO Chris Boerner said there's still interest in more business development.
Max Bayer
Feb 2, 2024 10:59am
BMS beat 2 other pharmas in bid for RayzeBio
Jan 25, 2024 1:35pm
Christmas deal spree: See what J&J, Roche had in their stockings
Jan 2, 2024 7:35am
BMS enters radiopharma race with $4.1B acquisition of RayzeBio
Dec 27, 2023 5:36am
Novartis, Lilly drive investor interest in radiopharmaceuticals
Dec 8, 2023 10:02am
RayzeBio scores $311M oversized IPO, Neumora hits $250M target
Sep 15, 2023 8:48am